Clinical and Economic Consequences of Delayed Transcatheter Aortic Valve Replacement.
作者信息
Weintraub William S
机构信息
MedStar Health Research Institute, Georgetown University, Washington, District of Columbia, USA.
出版信息
Struct Heart. 2024 Jun 24;8(6):100325. doi: 10.1016/j.shj.2024.100325. eCollection 2024 Nov.
Abstract
摘要
相似文献
1
Clinical and Economic Consequences of Delayed Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术延迟的临床和经济后果
Struct Heart. 2024 Jun 24;8(6):100325. doi: 10.1016/j.shj.2024.100325. eCollection 2024 Nov.
2
The delayed southern migration of a transcatheter aortic valve.经导管主动脉瓣的延迟南方迁徙。
Eur J Cardiothorac Surg. 2018 Jul 1;54(1):187-188. doi: 10.1093/ejcts/ezy008.
3
Length of Stay After Transfemoral Transcatheter Aortic Valve Replacement: An Analysis of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.经股动脉主动脉瓣置换术后的住院时间：胸外科医师学会/美国心脏病学会经导管瓣膜治疗登记处的分析。
JACC Cardiovasc Interv. 2019 Mar 11;12(5):422-430. doi: 10.1016/j.jcin.2018.11.015.
4
Association of Clinical and Economic Outcomes With Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后与永久性心脏起搏器植入相关的临床和经济结局。
JAMA Netw Open. 2018 May 18;1(1):e180088. doi: 10.1001/jamanetworkopen.2018.0088.
5
Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial.经导管主动脉瓣置换术与外科主动脉瓣置换术治疗低手术风险重度主动脉瓣狭窄患者的经济学结局：PARTNER 3 试验结果。
Circulation. 2023 May 23;147(21):1594-1605. doi: 10.1161/CIRCULATIONAHA.122.062481. Epub 2023 May 8.
6
A cost-utility analysis of transcatheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical risk.经导管主动脉瓣置换术与外科主动脉瓣置换术治疗中危外科手术风险主动脉瓣狭窄的成本-效用分析。
J Thorac Cardiovasc Surg. 2018 May;155(5):1978-1988.e1. doi: 10.1016/j.jtcvs.2017.11.112. Epub 2018 Feb 2.
7
Malnutrition Predicts Adverse Outcomes After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.营养不良预测经导管主动脉瓣置换术后不良结局：系统评价和荟萃分析。
Anatol J Cardiol. 2023 May;27(5):240-248. doi: 10.14744/AnatolJCardiol.2023.2710.
8
Impact of preprocedural mesenteric artery stenosis and mesenteric ischemia in patients undergoing transcatheter aortic valve replacement.经导管主动脉瓣置换术患者术前肠系膜动脉狭窄和肠系膜缺血的影响。
J Thorac Cardiovasc Surg. 2022 Nov;164(5):1458-1471.e6. doi: 10.1016/j.jtcvs.2022.03.015. Epub 2022 Mar 26.
9
Association of Acylcarnitines With Left Ventricular Remodeling in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术治疗重度主动脉瓣狭窄患者的酰基辅酶 A 与左心室重构的关系。
JAMA Cardiol. 2018 Mar 1;3(3):242-246. doi: 10.1001/jamacardio.2017.4873.
10
Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III Trial.在 REPRISE III 试验中经导管主动脉瓣置换术后起搏器植入和依赖情况。
J Am Heart Assoc. 2019 Nov 5;8(21):e012594. doi: 10.1161/JAHA.119.012594. Epub 2019 Oct 23.
本文引用的文献
1
Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.经股动脉 TAVR 或 SAVR 治疗的中危患者 5 年后的生活质量。
JACC Cardiovasc Interv. 2024 Apr 22;17(8):979-988. doi: 10.1016/j.jcin.2024.02.014.
2
Transcatheter or Surgical Treatment of Aortic-Valve Stenosis.经导管主动脉瓣置换术或主动脉瓣狭窄的外科治疗。
N Engl J Med. 2024 May 2;390(17):1572-1583. doi: 10.1056/NEJMoa2400685. Epub 2024 Apr 8.
3
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.2024 年心脏病与中风统计数据：美国心脏协会发布的美国和全球数据报告。
Circulation. 2024 Feb 20;149(8):e347-e913. doi: 10.1161/CIR.0000000000001209. Epub 2024 Jan 24.
4
Long-Term Survival and Quality of Life Following Transcatheter Aortic Valve Replacement in Nonagenarians.经导管主动脉瓣置换术在 90 岁以上患者中的长期生存和生活质量。
Am J Cardiol. 2024 Feb 15;213:140-145. doi: 10.1016/j.amjcard.2023.12.031. Epub 2023 Dec 21.
5
Aortic Stenosis: A 6-Decade Odyssey.主动脉瓣狭窄：六十年的历程
J Am Coll Cardiol. 2023 Nov 28;82(22):2110-2112. doi: 10.1016/j.jacc.2023.10.001. Epub 2023 Oct 24.
6
Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial.经导管主动脉瓣置换术与外科主动脉瓣置换术治疗低手术风险重度主动脉瓣狭窄患者的经济学结局：PARTNER 3 试验结果。
Circulation. 2023 May 23;147(21):1594-1605. doi: 10.1161/CIRCULATIONAHA.122.062481. Epub 2023 May 8.
7
Life Expectancy After Surgical Aortic Valve Replacement.主动脉瓣置换术后的预期寿命。
J Am Coll Cardiol. 2021 Nov 30;78(22):2147-2157. doi: 10.1016/j.jacc.2021.09.861.
8
Temporal Trends in Resource Use, Cost, and Outcomes of Transcatheter Aortic Valve Replacement in the United States.经导管主动脉瓣置换术在美国的资源利用、成本和结局的时间趋势。
Mayo Clin Proc. 2020 Dec;95(12):2665-2673. doi: 10.1016/j.mayocp.2020.05.043. Epub 2020 Nov 6.
9
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines.美国心脏病学会/美国心脏协会关于临床实践指南和绩效指标中成本/价值方法的声明：美国心脏病学会/美国心脏协会绩效指标特别工作组和实践指南特别工作组的报告
Circulation. 2014 Jun 3;129(22):2329-45. doi: 10.1161/CIR.0000000000000042. Epub 2014 Mar 27.
10
Transcatheter versus surgical aortic-valve replacement in high-risk patients.经导管主动脉瓣置换术与外科主动脉瓣置换术在高危患者中的比较。
N Engl J Med. 2011 Jun 9;364(23):2187-98. doi: 10.1056/NEJMoa1103510. Epub 2011 Jun 5.
Zotero 插件